Rheumatoid arthritis. (Q30244019)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Rheumatoid arthritis.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 June 2017

1 reference

Europe PubMed Central

Rheumatoid arthritis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 June 2017

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1

object named as

Josef S Smolen

1 reference

Europe PubMed Central

PubMed publication ID

12 June 2017

2

object named as

Daniel Aletaha

1 reference

Europe PubMed Central

PubMed publication ID

12 June 2017

3

object named as

Iain B McInnes

1 reference

Europe PubMed Central

PubMed publication ID

12 June 2017

language of work or name

0 references

publication date

3 May 2016

1 reference

Europe PubMed Central

PubMed publication ID

12 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 June 2017

388

1 reference

Europe PubMed Central

PubMed publication ID

12 June 2017

10055

1 reference

Europe PubMed Central

PubMed publication ID

12 June 2017

2023-2038

1 reference

Europe PubMed Central

PubMed publication ID

12 June 2017

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology and genetics of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Twin concordance rates for rheumatoid arthritis: results from a nationwide study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

To what extent is the familial risk of rheumatoid arthritis explained by established rheumatoid arthritis risk factors?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Familial aggregation of arthritis-related diseases in seropositive and seronegative rheumatoid arthritis: a register-based case-control study in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Psoriasis genetics: breaking the barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetics of rheumatoid arthritis contributes to biology and drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: a systematic literature review.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Autoantibody profiling in patients with very early rheumatoid arthritis: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Epigenetics in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel regulatory mechanisms in inflammatory arthritis: a role for microRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Personality, socio-economic status and inflammation: cross-sectional, population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Education, self‐care, and outcomes of rheumatic diseases: Further challenges to the “biomedical model” paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA molecules, bacteria and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

New therapies for treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The pathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The microbiome in infectious disease and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of the classical pathway of complement by rheumatoid factors. Assessment by radioimmunoassay for C4

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

IgM and IgA rheumatoid factors purified from rheumatoid arthritis sera boost the Fc receptor- and complement-dependent effector functions of the disease-specific anti-citrullinated protein autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflamed target tissue provides a specific niche for highly expanded T-cell clones in early human autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hunting for the pathogenesis of rheumatoid arthritis: core-needle biopsy of inguinal lymph nodes as a new research tool

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracellular signal pathways: potential for therapies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic strategies for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of ultrasound-guided small joint biopsy to evaluate the histopathologic response to rheumatoid arthritis therapy: recommendations for application to clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteoclasts are essential for TNF-alpha-mediated joint destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Metalloproteases and inhibitors in arthritic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Asymptomatic synovitis precedes clinically manifest arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenosynovitis and osteoclast formation as the initial preclinical changes in a murine model of inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Extraarticular manifestations of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A review of methotrexate-induced accelerated nodulosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A simplified disease activity index for rheumatoid arthritis for use in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA s

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin‐6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: The role of acute‐phase reactants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Metrologic properties of ultrasound versus clinical evaluation of synovitis in rheumatoid arthritis: results of a multicenter, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In patients with early rheumatoid arthritis, the new ACR/EULAR definition of remission identifies patients with persistent absence of functional disability and suppression of ultrasonographic synovitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Doppler ultrasound findings in healthy wrists and finger joints

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of patient outcome in arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The Effect of Glucocorticoids on Joint Destruction in Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Proposal for a new nomenclature of disease-modifying antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one-year double-blind study in 174 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapies for active rheumatoid arthritis after methotrexate failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Superior efficacy of combination therapy for rheumatoid arthritis: fact or fiction?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberculosis associated with therapy against tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Abatacept Inhibition of T Cell Priming in Mice by Induction of a Unique Transcriptional Profile That Reduces Their Ability to Activate Antigen-Presenting Cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Forget personalised medicine and focus on abating disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of combination therapies in the treatment of rheumatoid arthritis: leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: findings of a phase IIIb, multinational, prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The JAK-STAT pathway: impact on human disease and therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Tofacitinib versus methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Baricitinib in Patients with Refractory Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Infections in patients with rheumatoid arthritis treated with biologic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of RA medications in pregnant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of Tumor Necrosis Factor Inhibitors during Pregnancy and Breastfeeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: an exploratory analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolomics for rheumatic diseases: has the time come?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Goal-directed therapy for RA in routine practice is associated with improved function in patients with disease duration up to 15 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(16)30173-8

1 reference

Europe PubMed Central

PubMed publication ID

12 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30244019&oldid=1982976437"